正常孕妇血浆D-二聚体的检测与分析

doi:10.3969/j.issn.1673-8640.2014.10.002

摘要/Abstract

摘要：

目的探讨正常孕妇血浆D-二聚体的变化特点,建立本实验室正常孕妇血浆D-二聚体的参考区间。方法选取正常孕妇664例、非孕正常女性对照者100名(正常对照组),产后发生弥散性血管内凝血(DIC)或静脉血栓患者18例。将正常孕产妇按孕周分为5组:(1)孕<20周(127例);(2)孕20~32周(86例);(3) 孕32周至临产≥32周(191例);(4)产后第1天(130例);(5)产后第2天(130例)。采用SYSMEX CA7000全自动凝血仪检测所有正常孕妇及正常对照组血浆D-二聚体浓度,确定相应的参考区间。孕妇D-二聚体浓度呈偏态分布,采用百分位数(P95)表示参考区间的单侧上限。采用建立的参考区间评估18例产后发生DIC或静脉血栓孕产妇的D-二聚体水平,验证该参考区间的有效性。结果 D-二聚体随着妊娠期的延长逐渐升高,从20周开始至32周逐渐上升,32周以后升高幅度最大,孕<20周组、孕20~32周组及孕≥32周组D-二聚体参考区间分别为<1.54 mg/L、<3.46 mg/L及<4.96 mg/L ;分娩过程中D-二聚体发生了大幅度的变化,产后第l天急剧升高,至产后第2天明显下降,基本恢复至妊娠末期水平。产后第1天及产后第2天参考区间分别为<11.76 mg/L、<5.87 mg/L。5组间D-二聚体水平差异有统计学意义(P<0.001)。正常对照组和孕妇组D-二聚体浓度低于排除DVT临界值(0.5 mg/L)的比例分别为92.3%、55.1%、7.0%、1.0%、0.2%和0.7%。采用上述参考区间评估18例产后发生DIC或静脉血栓孕产妇的D-二聚体水平,均为阳性结果。结论初步建立本实验室正常孕妇血浆D-二聚体参考区间,妊娠中后期D-二聚体已不具备特异性,不能作为排除诊断依据。

关键词: D-二聚体, 孕妇, 参考区间

Abstract:

Objective To investigate the change characteristics of plasma D-dimer in healthy pregnant women and establish the reference range. Methods A total of 664 healthy pregnant women and 100 healthy women without pregnancy as control group were enrolled, and there were 18 cases of disseminated intravascular coagulation (DIC) or venous thrombosis after delivery. They were classified into 5 groups, pregnancy <20 weeks (127 cases), pregnancy 20-32 weeks (86 cases), pregnancy ≥32 weeks (191 cases), the first postpartum day (130 cases) and the second postpartum day (130 cases). D-dimer concentration was determined by SYSMEX CA7000 automatic coagulation analyzer in order to identify the reference range. Since D-dimer concentration showed non-normal distribution, the normal values were established by percentile (P95). The results of the 18 cases of DIC or venous thrombosis were used to validate the established normal values. Resutls D-dimer concentration increased continually with pregnancy from 20 weeks to 32 weeks, especially after 32 weeks. The reference ranges were <1.54 mg/L, <3.46 mg/L and <4.96 mg/L for pregnancy <20 weeks, 20-32 weeks and ≥32 weeks. D-dimer had a significant change during childbirth, and there was a sharp increasing in the first postpartum day and a significant decline in the second postpartum day recovering to the levels of late pregnancy, which the reference ranges were <11.76 mg/L and <5.87 mg/L, respectively.All groups had statistical significance for D-dimer concentration (P<0.001). The percentages of D-dimer which were lower than conventional critical value to exclude DVT (0.5 mg/L)were 92.3%, 55.1%, 7.0%, 1.0%, 0.2% and 0.7% in control group and 5 groups in pregnancy, respectively. All the 18 cases of DIC or venous thrombosis showed positive results by the above normal values. Conclusions By analyzing the change characteristics of D-dimer in healthy pregnant women, D-dimer reference ranges in healthy pregnant women are established. The D-dimer in middle and late pregnancy is not specific, which can not be as exclusion parameter.

Key words: D-dimer, Pregnant woman, Reference range

中图分类号:

R446.11

吴利, 周才, 黄瑞玉, 刘艳. 正常孕妇血浆D-二聚体的检测与分析[J]. 检验医学, 2014, 29(10): 992-994.

WU Li, ZHOU Cai, HUANG Ruiyu, LIU YAN.. Detection and analysis of plasma D-dimer in healthy pregnant women[J]. , 2014, 29(10): 992-994.

参考文献

[1] 陈化禹.D-二聚体及其测定方法探讨[J].实用医技杂志,2007,14(12):1567-1568.
[2] 陈彬, 梅树江. 确定多指标医学参考值范围的统计方法[J]. 西部医学, 2008 ,20 (6) :1353 -1354.
[3] 李帅,吕时铭,汤杰英.浙江地区汉族孕产妇D-二聚体参考区间的建立及应用[J].中华检验医学杂志,2011,34(7): 580-585.
[4] Isenegger J,Meier N,Lämmle B, et al. D-dimers prodict stoke subtype when assessed early[J].Cerebrovasc Dis,2010,29(1):82-86.
[5] Mauriello A, Sangiorgi G, Palmieri G, et al. Hyper-fibrinogenemia is associated with specific histocytological composition and complications of atherosclerotic carotid plaques in patients affected by transient ischemic attacks[J]. Circulation,2000,101(7):744-750.
[6] Ma WZ. Detection of hepatitis C virus antibody and its clinical significance[J]. Chinese Modern Doctor, 2008,46(13):159.
[7] 第七届全国血栓与止血学术会议制定的几项诊断参考标准[J].中华血液学杂志,2000,21(3):165-168.
[8] 张一鸣,蒋雅琴,袁佩,等. 孕妇血浆纤维蛋白原、D-二聚体和AT-Ⅲ动态检测的临床意义[J].临床检验杂志,2007,25(3):229.
[9] Marik PE, Plante LA. Venous thromboembolic disease and pregnancy[J]. N Engl J Med, 2008, 359(19): 2025-2033.
[10] Heit JA,Kobbervig CE,James AH,et al.Trends in the incidence of venous thromboembolism during pregnancy or postpartum:a 30-year population-based study[J]. Ann Intern Med,2005,143(10): 697-706.
[11] 刘小华,程蔚蔚.孕晚期部分凝血及纤溶指标的检测对低危产妇产后出血的预测价值[J]. 检验医学,2013, 28 (6): 492-495.
[12] Kovac M, Mikovic Z,Rakicevic L,et al. The use of D-dimer with new cutoff can be useful in diagnosis of venous thromboembolism in pregnancy[J]. Eur J Obstet Gynecol Reprod Biol, 2010, 148(1): 27-30.
[13] 沙德顺,沙敏. 围产期孕妇D-二聚体参考范围的调查[J]. 医学检验与临床,2010,21(3): 127.

[1]	顾玉, 梁晓艳, 马胜辉, 佟娜, 程明艳, 阎泽君. 血浆生物标志物在慢性肾脏病伴血栓栓塞患者中的表达及其近期预后评估价值[J]. 检验医学, 2023, 38(12): 1177-1182.
[2]	安映红, 姚克纯, 苏成铭, 唐锦华, 杨利鑫, 高洁, 徐艳婷, 严秋红, 战宏艳, 马越云. 北京地区表观健康人群同型半胱氨酸水平调查[J]. 检验医学, 2023, 38(11): 1036-1040.
[3]	赵艳宏, 傅琳, 刘彪, 肖美芳. 海南地区3~14岁人群乳酸脱氢酶参考区间分析[J]. 检验医学, 2023, 38(11): 1041-1043.
[4]	宗健敏, 肖姗, 姜玲, 蒋钰. 性别、年龄和季节对睾酮参考区间的影响[J]. 检验医学, 2023, 38(10): 980-982.
[5]	张辉, 费阳, 张驰, 陈俊昆, 李果. 武汉地区0~3 d新生儿网织血小板参数参考区间[J]. 检验医学, 2023, 38(1): 69-72.
[6]	罗国菊, 金晶, 徐佳, 郝英英, 汪晓巍, 郭野. UF-5000全自动尿液分析仪健康成人全参数参考区间分析[J]. 检验医学, 2022, 37(8): 751-753.
[7]	徐倩倩, 姜王庆, 沈林杰, 陆英杰, 陈健, 蒋浩琴. 上海地区成人网织红细胞相关参数参考区间的建立[J]. 检验医学, 2022, 37(7): 641-645.
[8]	李雪文, 徐攀洋, 何冰, 邢东洋, 夏薇, 许建成. 间接法建立长春地区成人血清淀粉酶参考区间[J]. 检验医学, 2022, 37(5): 493-495.
[9]	苗林子, 陆遥, 屈晨雪, 由然, 龚岩. 健康成人白细胞表面CD64和HLA-DR相关指标参考区间的建立及其影响因素分析[J]. 检验医学, 2022, 37(3): 240-245.
[10]	李熙建, 张立营, 刘影, 龙琴, 沈伟. 青藏高原藏族人群6个血细胞分析项目参考区间的建立[J]. 检验医学, 2022, 37(3): 249-253.
[11]	成景松, 阮家安, 孟建华. 血浆DD联合GRACE评分在老年急性心肌梗死预后评估中的价值[J]. 检验医学, 2022, 37(2): 162-164.
[12]	陆优丽, 杨双双, 张美微, 欧美贤, 董春霞, 沈薇薇, 姜凤丽, 李水军. 超高效液相色谱串联质谱同时检测人血清5种甾体激素方法学及生物参考区间的建立[J]. 检验医学, 2022, 37(2): 165-173.
[13]	徐志刚, 卢霞, 龚晓霖. CA125、Fib、DD在卵巢癌化疗疗效评估中的价值[J]. 检验医学, 2022, 37(11): 1104-1105.
[14]	余建洪, 彭庆远, 殷明刚. 自贡地区表观健康成人血清PGⅠ、PGⅡ和PGR参考区间的建立[J]. 检验医学, 2022, 37(1): 23-27.
[15]	胡兵, 李改, 张会敏. 血清IL-6、DD水平在预测高血压患者脑出血风险中的作用[J]. 检验医学, 2022, 37(1): 63-67.